136 related articles for article (PubMed ID: 7758222)
1. Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL).
Fournier N; Myara I; Atger V; Moatti N
Clin Chim Acta; 1995 Jan; 234(1-2):47-61. PubMed ID: 7758222
[TBL] [Abstract][Full Text] [Related]
2. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.
Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA
Diabetologia; 2007 Mar; 50(3):643-53. PubMed ID: 17216278
[TBL] [Abstract][Full Text] [Related]
3. Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity.
Sparks DL; Anantharamaiah GM; Segrest JP; Phillips MC
J Biol Chem; 1995 Mar; 270(10):5151-7. PubMed ID: 7890624
[TBL] [Abstract][Full Text] [Related]
4. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
Sparks DL; Frank PG; Neville TA
Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding.
Bolin DJ; Jonas A
J Biol Chem; 1996 Aug; 271(32):19152-8. PubMed ID: 8702592
[TBL] [Abstract][Full Text] [Related]
6. Binding affinity and reactivity of lecithin cholesterol acyltransferase with native lipoproteins.
Kosek AB; Durbin D; Jonas A
Biochem Biophys Res Commun; 1999 May; 258(3):548-51. PubMed ID: 10329423
[TBL] [Abstract][Full Text] [Related]
7. Decreased activation of lecithin:cholesterol acyltransferase by glycated apolipoprotein A-I.
Calvo C; Ulloa N; Del Pozo R; Verdugo C
Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):217-20. PubMed ID: 8318568
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of HDL subfractions towards lecithin-cholesterol acyltransferase. Modulation by their content in free cholesterol.
Simard G; Loiseau D; Girault A; Perret B
Biochim Biophys Acta; 1989 Oct; 1005(3):245-52. PubMed ID: 2804054
[TBL] [Abstract][Full Text] [Related]
9. Formation of pregnenolone- and dehydroepiandrosterone-fatty acid esters by lecithin-cholesterol acyltransferase in human plasma high density lipoproteins.
Lavallée B; Provost PR; Belanger A
Biochim Biophys Acta; 1996 Feb; 1299(3):306-12. PubMed ID: 8597585
[TBL] [Abstract][Full Text] [Related]
10. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
O K; Hill JS; Pritchard PH
Biochim Biophys Acta; 1995 Jan; 1254(2):193-7. PubMed ID: 7827124
[TBL] [Abstract][Full Text] [Related]
11. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation.
Labeur C; Lambert G; Van Cauteren T; Duverger N; Vanloo B; Chambaz J; Vandekerckhove J; Castro G; Rosseneu M
Atherosclerosis; 1998 Aug; 139(2):351-62. PubMed ID: 9712342
[TBL] [Abstract][Full Text] [Related]
12. Lecithin:cholesterol acyltransferase-mediated modification of discoidal peripheral lymph high density lipoproteins: possible mechanism of formation of cholesterol-induced high density lipoproteins (HDLc) in cholesterol-fed dogs.
Dory L; Sloop CH; Boquet LM; Hamilton RL; Roheim PS
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3489-93. PubMed ID: 6574494
[TBL] [Abstract][Full Text] [Related]
13. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
[TBL] [Abstract][Full Text] [Related]
14. Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase.
Gong EL; Nichols AV; Weisgraber KH; Forte TM; Shore VG; Blanche PJ
Biochim Biophys Acta; 1989 Dec; 1006(3):317-28. PubMed ID: 2597674
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease.
Rye KA
Clin Exp Nephrol; 2014 Apr; 18(2):247-50. PubMed ID: 24052156
[TBL] [Abstract][Full Text] [Related]
16. [Protective effect of high density lipoproteins, their subfractions and lecithin-cholesterol-acyltransferases on the peroxidation modification of low density lipoproteins].
Klimov AN; Nikiforova AA; Pleskov VM; Kuz'min AA; Kalashnikova NN
Biokhimiia; 1989 Jan; 54(1):118-23. PubMed ID: 2719985
[TBL] [Abstract][Full Text] [Related]
17. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
Calabresi L; Franceschini G
Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
[TBL] [Abstract][Full Text] [Related]
18. Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins.
Vickaryous NK; Teh EM; Stewart B; Dolphin PJ; Too CK; McLeod RS
Biochim Biophys Acta; 2003 Mar; 1646(1-2):164-72. PubMed ID: 12637024
[TBL] [Abstract][Full Text] [Related]
19. Lecithin:cholesterol acyltransferase-induced modifications of liver perfusate discoidal high density lipoproteins from African green monkeys.
Babiak J; Tamachi H; Johnson FL; Parks JS; Rudel LL
J Lipid Res; 1986 Dec; 27(12):1304-17. PubMed ID: 3559393
[TBL] [Abstract][Full Text] [Related]
20. The in vitro formation of HDL2 during the action of LCAT: the role of triglyceride-rich lipoproteins.
Dieplinger H; Zechner R; Kostner GM
J Lipid Res; 1985 Mar; 26(3):273-82. PubMed ID: 3989387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
